Chron­ic wound biotech rais­es $26M in Se­ries D to ex­pand blood clot prod­ucts

3 years ago
Financing

With Mod­er­na wind­fall, Har­vard pro­fes­sor and in­te­grins leg­end Tim Springer do­nates $210M to his In­sti­tute for Pro­tein ...

3 years ago
People
Financing

El­e­vate­Bio snags the year's largest raise with $401M Se­ries D, plus a re­search part­ner­ship with No­vo

3 years ago
Financing
Cell/Gene Tx

Atea con­firms un­so­licit­ed cash pro­pos­al from Tang Cap­i­tal’s Con­cen­tra, the shell buy­ing Jounce Ther­a­peu­tics

3 years ago
Deals

Di­ag­nos­tics out­fit lays off third of em­ploy­ees, now look­ing at 's­trate­gic al­ter­na­tives'

3 years ago
People
Diagnostics

Am­gen, Janssen reach set­tle­ment on Ste­lara biosim­i­lar drug, al­low­ing for 2025 launch at lat­est

3 years ago
Pharma
Law

Com­pa­nies ask FDA for reg­u­la­tion, im­prove­ment of da­ta col­lec­tion from dig­i­tal health de­vices

3 years ago
Pharma
FDA+

FDA warns Sure-BioChem over qual­i­ty and da­ta is­sues

3 years ago
Pharma
FDA+

Wal­greens asks fed­er­al court to toss Hu­mana's $642M pay­out in drug pric­ing case

3 years ago
Pharma
Law

House com­mit­tee takes on PBMs as bi­par­ti­san sup­port for wider re­forms grows

3 years ago
Pharma

Mar­ket­ingRx roundup: Mod­er­na, Pfiz­er, J&J top phar­mas on in­no­va­tion list; Bris­tol My­ers taps IPG for me­dia

3 years ago
Pharma
Marketing

Weight loss field ex­pands as Pfiz­er's oral GLP-1 gath­ers com­par­isons to Novo's We­govy in PhII da­ta

3 years ago
R&D
Pharma

FDA grants an ex­pand­ed Ay­vak­it la­bel to Blue­print Med­i­cines

3 years ago
FDA+

Af­fimed lays off around 50 staffers as it brings com­bo NK cell ther­a­py to PhII

3 years ago
People
R&D

An ear­ly-stage fail high­lights on­go­ing ALS drug de­vel­op­ment chal­lenges, de­spite re­cent Bio­gen OK

3 years ago
R&D

PhI­II win for smok­ing ces­sa­tion treat­ment puts Achieve Life Sci­ences on path to FDA, jazzes up deal talks

3 years ago
R&D

Co­hBar, Mor­pho­gen­e­sis link up in re­verse merg­er of two can­cer biotechs

3 years ago
Deals
R&D

Lark­spur Bio­sciences kicks off with $30M+, hunt­ing for new on­col­o­gy im­munother­a­pies

3 years ago
Financing
Startups

Who else want­ed to buy Iver­ic? Be­fore the $5.9B Astel­las deal, five bio­phar­ma com­pa­nies took a look

3 years ago
Deals
Pharma

In wake of Ru­bius down­fall, a new biotech spin­out launch­es to 'take the next step' in red blood cell ther­a­pies

3 years ago
Startups
Cell/Gene Tx

Icosavax push­es for­ward com­bo RSV-hM­PV vac­cine and an­nounces di­rect stock of­fer­ing

3 years ago
Financing
R&D

FDA ap­proves an­oth­er new type of opi­oid over­dose an­ti­dote nasal spray

3 years ago
FDA+

Back Bay makes deal with Nor­way's DNB in bank­ing and ad­vi­so­ry part­ner­ship

3 years ago
Financing
Deals

Roche scraps sec­ond mid-stage schiz­o­phre­nia tri­al in as many years

3 years ago
R&D
Pharma
First page Previous page 338339340341342343344 Next page Last page
A service from the Financial Times